Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Consolidated Edison
ED
$39.3B
| $1.05M | 0.07% |
13,500
+7,292
| +117% | +$639K |
|
352
Telephone and Data Systems
TDS
$3.87B
| $1.05M | 0.07% |
62,812
-18,874
| -23% | -$410K |
|
|
RETA
353
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.05M | 0.07% |
7,275
-10,301
| -59% | -$1.99M |
|
|
WCC
354
WESCO International
WCC
$17B
| $1.05M | 0.07% |
45,878
+27,778
| +153% | +$1.18M |
|
355
PBF Energy
PBF
$8.72B
| $1.05M | 0.07% |
147,729
+117,194
| +384% | +$2.63M |
|
356
Teva Pharmaceuticals
TEVA
$43.5B
| $1.04M | 0.07% |
116,300
+85,500
| +278% | +$876K |
|
357
Assured Guaranty
AGO
$3.27B
| $1.03M | 0.07% |
40,081
+30,483
| +318% | +$1.26M |
|
358
GSK
GSK
$105B
| $1.03M | 0.06% |
+21,694
| New | +$1.16M |
|
359
JB Hunt Transport Services
JBHT
$25.9B
| $1.03M | 0.06% |
11,137
+4,696
| +73% | +$488K |
|
360
Johnson & Johnson
JNJ
$651B
| $1.03M | 0.06% |
7,825
-82,740
| -91% | -$11.7M |
|
361
Ares Capital
ARCC
$14.3B
| $1.02M | 0.06% |
95,100
+9,300
| +11% | +$157K |
|
362
Enovis
ENOV
$1.5B
| $1.02M | 0.06% |
29,863
+25,099
| +527% | +$1.38M |
|
363
Reinsurance Group of America
RGA
$15.9B
| $1.02M | 0.06% |
+12,100
| New | +$1.58M |
|
364
Algonquin Power & Utilities
AQN
$4.39B
| $1.01M | 0.06% |
+75,273
| New | +$1.1M |
|
|
ATNX
365
DELISTED
Athenex, Inc. Common Stock
ATNX
| $1.01M | 0.06% |
6,547
-35,179
| -84% | -$8.86M |
|
366
Charles River Laboratories
CRL
$14.1B
| $1.01M | 0.06% |
8,022
+6,370
| +386% | +$955K |
|
367
TC Energy
TRP
$64.6B
| $1.01M | 0.06% |
+22,701
| New | +$1.15M |
|
|
QTNT
368
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.01M | 0.06% |
6,374
-14,843
| -70% | -$3.89M |
|
369
Paycom
PAYC
$10.3B
| $1M | 0.06% |
+4,958
| New | +$1.36M |
|
370
IQVIA
IQV
$42.8B
| $1M | 0.06% |
9,284
-3,107
| -25% | -$444K |
|
371
Public Service Enterprise Group
PEG
$36.2B
| $1M | 0.06% |
22,300
-43,100
| -66% | -$2.33M |
|
372
Helmerich & Payne
HP
$4.35B
| $996K | 0.06% |
63,638
+43,538
| +217% | +$1.53M |
|
373
Oracle
ORCL
$422B
| $995K | 0.06% |
20,595
-21,669
| -51% | -$1.12M |
|
374
NovoCure
NVCR
$1.99B
| $988K | 0.06% |
+14,674
| New | +$1.16M |
|
375
NRG Energy
NRG
$23.8B
| $987K | 0.06% |
36,189
-70,019
| -66% | -$2.41M |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.